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ABSTRACT Multiple sclerosis (MS) is an autoimmune disease of the central nervous
system characterized by adaptive and innate immune system dysregulation. Recent
work has revealed moderate alteration of gut microbial communities in subjects
with MS and in experimental, induced models. However, a mechanistic understand-
ing linking the observed changes in the microbiota and the presence of the disease
is still missing. Chloroform-resistant, spore-forming bacteria, which primarily belong
to the classes Bacilli and Clostridia in the phylum Firmicutes, have been shown to ex-
hibit immunomodulatory properties in vitro and in vivo, but they have not yet been
characterized in the context of human disease. This study addresses the commu-
nity composition and immune function of this bacterial fraction in MS. We iden-
tify MS-associated spore-forming taxa (primarily in the class Clostridia) and show
that their presence correlates with impaired differentiation of IL-10-secreting,
regulatory T lymphocytes in vitro. Colonization of antibiotic-treated mice with
spore-forming bacteria allowed us to identify some bacterial taxa favoring IL-10
lymphocyte differentiation and others inducing differentiation of proinﬂamma-
tory, IFN- T lymphocytes. However, when fed into antibiotic-treated mice,
both MS and control-derived spore-forming bacteria were able to induce similar
IL-10-expressing Treg immunoregulatory responses, thus ameliorating symptoms
of experimental allergic encephalomyelitis (EAE). Our analysis also identiﬁed Ak-
kermansia muciniphila as a key organism that may interact either directly or indi-
rectly with spore-forming bacteria to exacerbate the inﬂammatory effects of MS-
associated gut microbiota. Thus, changes in the spore-forming fraction may
inﬂuence T lymphocyte-mediated inﬂammation in MS. This experimental ap-
proach of isolating a subset of microbiota based on its functional characteristics
may be useful to investigate other microbial fractions at greater depth.
IMPORTANCE To address the impact of microbiome on disease development, it is
essential to go beyond a descriptive study and evaluate the physiological impor-
tance of microbiome changes. Our study integrates computational analysis with in
vitro and in vivo exploration of inﬂammatory properties of spore-forming microbial
communities, revealing novel functional correlations. We speciﬁcally show that while
small differences exist between the microbiomes of MS patients and healthy sub-
jects, these differences are exacerbated in the chloroform-resistant fraction. We fur-
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Differences between gut microbes in
multiple sclerosis patients and healthy controls
are exacerbated when search focuses on
spore-forming bacteria. Several of these bugs
found to modulate immune responses.
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ther demonstrate that, when puriﬁed from MS patients, this fraction is correlated
with impaired immunomodulatory responses in vitro.
KEYWORDS immune mechanisms, multiple sclerosis, spore-forming bacteria
The human gut microbiota is emerging as a major immune regulator in health anddisease, particularly in relation to autoimmune disorders. Most human microbiota
studies to date have been based on unbiased exploration of complete microbial
communities. However, limited sequencing depth, combined with high community
richness and natural sample heterogeneity, might hinder the discovery of physiologi-
cally relevant taxonomical differences. Thus, targeted studies of speciﬁc microbial
populations with deﬁned characteristics may serve as a complementary approach to
investigate disease-associated changes in gut microbiome.
Spore-forming bacteria constitute a subset of Gram-positive bacteria that are resis-
tant to 3% chloroform treatment (1, 2) as well as other harsh conditions and show lower
variability between humans compared to the total bacterial fraction (3). Both human
and mouse spore-forming bacteria have immunoregulatory functions (4, 5). Mouse
spore-forming bacteria include segmented ﬁlamentous bacteria and Clostridia species,
which have been shown to induce gut T helper lymphocyte responses (4, 6). More
recently, human spore-forming bacteria from a healthy subject were also reported to
induce Tregs in vitro and in gnotobiotic mice (5). However, whether the composition
and functions of spore-forming bacteria are altered in immune-mediated diseases is
unknown.
Multiple sclerosis (MS) is a chronic disease of the central nervous system, charac-
terized by autoimmune destruction of myelin. MS pathogenesis is in part mediated by
effector T lymphocytes, and counterbalanced by Tregs, which limit the autoimmune
damage inﬂicted by the former population (7, 8) and potentially promote remyelination
(9). Recent studies, including our own, associated MS with moderate changes in the
relative amounts of gut microbiota that exacerbate T lymphocyte-mediated inﬂamma-
tion in vitro and in vivo by stimulating pro-inﬂammatory IFN- Th1 and inhibiting
IL-10 regulatory T lymphocytes (10, 11).
We hypothesized that these MS-associated changes in gut microbial communities
may involve spore-forming bacteria, thus altering their overall immunoregulatory
properties. To address this hypothesis, we isolated spore-forming bacteria from un-
treated patients with relapsing-remitting MS (RRMS) and matched controls to analyze
their structural composition by 16S rRNA gene sequencing. Furthermore, we also
analyzed their immunoregulatory functions both in vitro and in the experimental
autoimmune encephalomyelitis (EAE) mouse model.
RESULTS
MS-associated differences in microbial community composition are more evi-
dent in the spore-forming fraction. We isolated the spore-forming bacterial fraction
from stool samples of 25 untreated MS patients and 24 controls and tested their relative
abundance by amplicon sequencing of 16S rRNA V4 gene sequences. As expected, the
observed overall complexity of each community was reduced (3) and no major differ-
ences in community richness between patients and controls were identiﬁed (Chao1
metric of alpha diversity, Fig. 1A) (Tables S2 and S3 in the supplemental material list the
different OTUs detected after chloroform extraction in controls and cases, respectively).
However, when bacterial abundances in the spore-forming fraction were analyzed at
the OTU level, clear differences between cases and controls emerged (Fig. 1B). Specif-
ically, 22.43% (135 out of 602 total) of OTUs were signiﬁcantly different between cases
and controls (P  0.05, negative binomial Wald test, Benjamini-Hochberg correction)
(Fig. 1D and Table S1). These taxonomical differences were noticeable even at the class
level in which Bacilli were signiﬁcantly overrepresented in controls (Fig. 1E), and
Clostridia (including Clostridium perfringens) were signiﬁcantly overrepresented in MS
patients (Fig. 1F and Fig. S1).
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Spore-forming bacteria from MS patients fail to induce anti-inﬂammatory T
lymphocytes in vitro. To investigate whether MS-associated differences in community
composition of spore-forming bacteria were sufﬁcient to alter the immune functions of
primary blood mononuclear cells (PBMCs) from healthy human donors, we exposed
human PBMCs to extracts of spore-forming bacteria isolated either from unrelated
controls or from MS patients and used ﬂow cytometry to evaluate T lymphocyte
differentiation under different polarizing conditions (12–14). A comparison of the PBMC
response to extracts of spore-forming bacteria from controls or from MS patients
identiﬁed lower conversion into CD4 FoxP3 Tregs (Fig. 2A and C), including the
FIG 1 Differences in community composition of spore-forming bacterial fraction in MS patients and
healthy controls. (A to C) Comparison of microbial community composition of spore-forming bacterial
subset and total stool bacteria in untreated MS patients (n  25) and controls (n  24). (A) Chao1 metric
of alpha diversity. (B) Median and range of distances (unweighted UniFrac distance matrix) within and
between sample groups. (C) Mean relative abundance of microbial genera. (D to F) Comparison of
relative abundances of individual microbial taxa in untreated MS patients (n  25) and controls (n  24).
(D) Volcano plot of relative abundance distribution of microbial OTUs. x axis, log2 fold of relative
abundance ratio between MS patients and controls after variance-stabilizing transformation. y axis,
negative log10 of P value, negative binomial Wald test, Benjamini-Hochberg correction for multiple
comparisons. (E and F) Relative abundances of bacterial classes Bacilli (E) and Clostridia (F) within phylum
Firmicutes out of spore-forming bacteria from controls and MS patients. Error bars, mean  SEM. CTRL,
total stool bacteria from controls. CTRL_spore, spore-forming bacteria from controls. MS, total stool
bacteria from MS patients. MS_spore, spore-forming bacteria from MS patients.
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IL-10-expressing Treg population (Fig. 2B and D) in the PBMCs exposed to the MS-
derived spore-forming bacteria. These data suggest that spore-forming bacteria from
MS patients are signiﬁcantly less effective at inducing Treg differentiation. Of note, the
small population of Tregs that still differentiated in response to MS bacteria retained
their suppressive capacities in vitro (Fig. 2E), thereby indicating that this was a func-
tionally active population. Interestingly, the percentage of IL-10 Tregs induced by
extracts of spore-forming bacteria positively correlated with the relative abundance of
Bacilli and negatively correlated with the relative abundance of Clostridia (Fig. 2F,
expressed as Clostridia-Bacilli difference). Thus, the community composition of spore-
forming bacteria (i.e., high Clostridia, low Bacilli) associated with MS was also correlated
with an inhibition of their respective immunoregulatory functions.
Antibiotic-treated and recolonized mouse models reveal associations between
individual bacterial taxa and T lymphocyte responses. To determine whether the
MS-associated reduction in the ability of spore-forming bacteria to stimulate Treg
differentiation was physiologically signiﬁcant, we colonized a group of female
FIG 2 Spore-forming bacteria from MS patients inhibit IL-10 Treg differentiation in vitro. (A and B) Representative
ﬂow cytometry plots (A) and quantiﬁcation (B) of CD4 FoxP3 Tregs within CD3 lymphocytes differentiated in
response to spore-forming bacteria isolated from controls or untreated MS patients. n  7 PBMC donors; each dot
represents an average response from PBMC donor to isolates from 6 control or MS bacterial donors. **, P 0.01,
two-tailed repeated measures t test. (C and D) Representative ﬂow cytometry plots (C) and quantiﬁcation (D) of
IL-10 lymphocyte population within CD3 CD4 FoxP3 Tregs differentiated in response to spore-forming
bacteria isolated from controls or untreated MS patients. n 6 bacterial donors per group. *, P 0.05, two-tailed
t test. Error bars, mean  SEM. The experiment was repeated with nonoverlapping PBMC and bacterial donors and
gave the same results. (E) Quantiﬁcation of T effector cell proliferation in response to Tregs differentiated in the
presence of spore-forming bacteria from MS patients or controls. n 3 bacterial donors per group, each repre-
senting an average of 3 technical replicates. (F) Linear correlation between IL-10 population within CD3 CD4
FoxP3 Tregs and Clostridia-Bacilli relative abundances. R2  0.214, P 0.0459. Black dots, MS patients. Light gray
dots, controls.
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antibiotic-treated mice (15) with spore-forming bacteria from either controls (n  2) or
MS subjects (n  2) and measured the course and severity of experimental allergic
encephalomyelitis (EAE). We observed a signiﬁcant reduction in disease severity in all
mice whose GI tracts were reconstituted with spore-forming bacteria. However, this
reduction was independent of whether the spore-forming fraction was isolated from
MS or controls (Fig. 3A). This indicated that while MS-derived spore-forming bacteria
could be functionally distinguished in vitro, these differences were not sufﬁcient to
induce a phenotype in vivo in our experimental setting.
We next analyzed whether spore-forming bacteria regulated T lymphocyte re-
sponses in vivo. To this end, we colonized antibiotic-treated mice with spore-forming
bacteria from 3 controls and 3 MS patients and analyzed the resulting changes in
bacterial composition and T lymphocyte differentiation. Principal coordinate analysis
(PCoA) of the beta diversity of gut microbiota separated SPF mice from antibiotic-
treated and recolonized mice. While no major shifts in community composition based
on disease state of the donor were observed (Fig. 3B), multiple microbial taxa were
differentially abundant (Fig. 3C; Tables S4 and S5), including an increase in Akkermansia
(3 OTUs corresponding to A. muciniphila) (Table S5) in mice colonized with spore-
forming bacteria from MS patients. Further investigation identiﬁed individual taxa that
were classiﬁed as either putatively proinﬂammatory or anti-inﬂammatory based on the
correlation between their relative abundance in mouse stool samples and their ability
to alter differentiation of IFN- Th1 or IL-10 regulatory lymphocytes from either
spleen or mesenteric lymph nodes (MLN) in vitro (Fig. 3D and E). The putative proin-
ﬂammatory category (Fig. 3D, red rectangle) included taxa signiﬁcantly increased in
mice colonized with spore-forming bacteria from MS patients compared to controls
(highlighted in red), while the putative anti-inﬂammatory category (mostly evident in
splenocytes; blue rectangle) contained taxa signiﬁcantly reduced in mice colonized
with spore-forming bacteria from MS patients (highlighted in blue).
The increase in Akkermansia muciniphila, a non-spore-forming bacterium, in
antibiotic-treated mice colonized with spore-forming bacteria from MS patients led to
the hypothesis that spore-forming bacteria may regulate Akkermansia levels. The
correlation between spore-forming community composition and relative abundance of
Akkermansia is shown in Fig. 4A. The increase in Akkermansia was present not only in
the mice colonized with spore-forming bacteria from MS donors but also in MS donors
themselves (P 1.5E09, negative binomial Wald test) (Fig. 4B). Of interest, we and
others (10, 11) recently reported the increased abundance of Akkermansia in untreated
MS patients and identiﬁed this bacterium as sufﬁcient for driving T lymphocyte
differentiation into the proinﬂammatory IFN- Th1 phenotype in vitro (11). Consistent
with this result, we also observed a signiﬁcant positive correlation between the relative
abundance of Akkermansia and IFN- Th1 lymphocyte differentiation (Fig. 4C) in
antibiotic-treated and recolonized mice. While other taxa also correlated with Akker-
mansia levels and T lymphocyte differentiation (Fig. 4D), our data suggest that the
observed immunological effects may be mediated by Akkermansia either directly, by
shifting immune responses toward a Th1 phenotype (10), or indirectly, by affecting
mucosal thickness and therefore stool transit time, potentially altering the growth of
other communities with proinﬂammatory characteristics.
DISCUSSION
The spore-forming fraction of gut bacteria has been associated with immunoregu-
latory properties (5). Here we examined the structural composition and immunological
effects of the culturable spore-forming fraction of gut microbiota from subjects with MS
compared to controls. MS-associated differences in bacterial community composition
were correlated with impaired anti-inﬂammatory functions, as evidenced by a reduc-
tion in their ability to drive T lymphocyte differentiation into IL-10 Tregs in vitro.
Furthermore, colonizing antibiotic-treated mice with spore-forming bacteria allowed us
to identify speciﬁc taxa correlated with T lymphocyte differentiation into IFN- and
IL-10 subtypes in vivo.
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FIG 3 Spore-forming bacterial composition is correlated with T lymphocyte phenotypes in vivo. (A) Clinical EAE scores of mice that after antibiotic treatment
had been colonized with spore-forming bacteria from controls (CTRL_spore) or MS patients (MS_spore) for 2 weeks or kept on antibiotics (ABX) or under SPF
conditions as controls, prior to induction of EAE at 9 to 10 weeks of age. n 5 to 10 mice per group. (B and C) Principal coordinate plot of beta diversity (PCoA;
unweighted UniFrac) (B) and genus-level taxonomical distribution (C) of mouse fecal microbiota at 2 weeks of colonization with spore-forming bacteria, 2
separate experiments. (D) Bacterial genera whose abundance is correlated with changes in immune cell differentiation in antibiotic-treated and recolonized
(Continued on next page)
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Our results contribute to the evidence supporting the immunoregulatory functions
of spore-forming bacteria and show that these functions may be compromised in the
context of autoimmunity. Some of the previous studies on spore-forming bacteria had
been conducted by isolating this fraction from a single healthy donor (5, 16). This
approach allowed focusing on donor-speciﬁc bacterial strains, but provided limited
information about the “baseline” composition and variability of this bacterial commu-
nity in healthy humans. Another recent study has compared multiple donors and
discovered that spore-forming bacteria have reduced variability between subjects and
respond to shared environmental signals, and in particular, dietary fatty acids, that
likely mediate colonization of recently disturbed human guts (3). Here we used multiple
healthy control donors to establish the baseline community composition of spore-
forming bacteria, and compared these healthy proﬁles with those from patients with
MS. MS is signiﬁcantly more prevalent in women than in men; as a result there is always
a gender disparity between cases and controls. However, at baseline there are few
differences in microbiome between genders (17).
Our data corroborate previous ﬁndings that spore-forming bacteria, almost exclu-
sively belonging to the phylum Firmicutes, and classes Clostridia and Bacilli, induce
anti-inﬂammatory T lymphocytes in vitro and protect from autoimmune inﬂammation
in vivo (5, 6). We also show that the taxonomical distribution and immunoregulatory
functions of spore-forming bacteria are altered in MS patients. While we identiﬁed
FIG 3 Legend (Continued)
mice are shown. The linear correlation between relative abundances of bacterial genera and the percentage of IL-10 regulatory and IFN- Th1 out of CD4
Th lymphocytes from both spleens and mesenteric lymph nodes (MLN) of mice colonized with spore-forming bacteria is depicted as a heat map. Same samples
as in panels B and C. Only the genera that show signiﬁcant linear correlation with immune parameters (P 0.05 after Benjamini-Hochberg adjustment for
multiple comparisons) are included in the heat map. Red rectangle, putative proinﬂammatory subset. Blue rectangle, putative anti-inﬂammatory subset. Red
font, taxa signiﬁcantly increased in mice colonized with spore-forming bacteria from MS patients compared to controls. Blue font, taxa signiﬁcantly reduced
in mice colonized with spore-forming bacteria from MS patients compared to controls. (E) Examples of positive and negative correlation between bacteria and
Th lymphocyte differentiation from panel D.
FIG 4 Increased Akkermansia is linked with MS-associated changes in spore-forming bacteria and proinﬂammatory T
lymphocytes. (A) Principal coordinate plot of beta diversity (PCoA; unweighted UniFrac) of mouse fecal microbiota excluding
Akkermansia at 2 weeks of colonization with spore-forming bacteria, 2 separate experiments, colored by Akkermansia presence
(red to green: low to high). P 0.001, signiﬁcant contribution of Akkermansia presence to determining distance variation
(Adonis method for continuous variables). (B) Relative abundance of Akkermansia in controls and MS patients used for isolation
of spore-forming bacteria. P 1.5E09, negative binomial Wald test, Benjamini-Hochberg correction for multiple comparisons
(across all 144 species detected in the data set). (C) Linear correlation of relative abundance of Akkermansia with IFN- Th1
lymphocyte differentiation in spleens of mice colonized with spore-forming bacteria. R2 0.18, P 0.0003. (D) Bacterial genera
signiﬁcantly correlated with Akkermansia in vivo.
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putative proinﬂammatory and anti-inﬂammatory taxa, their physiological functions
remain to be determined, for example, by mouse monocolonization experiments as
recently reported (18) While we were able to show that these differences have
functional consequences in vitro, they were not sufﬁcient to alter the course of EAE
using antibiotic-treated mice. One possible explanation for this counterintuitive ﬁnding
is that since our mice were treated with antibiotics, they were not germfree prior to
colonization. As a consequence, unexpected interactions among antibiotic-resistant
communities and the spore-forming fraction may have inﬂuenced the course of EAE. In
addition, the fact that EAE immunization uses a microbial adjuvant (Mycobacterium
tuberculosis) may have reduced the impact of microbiome on the immune response. We
recognize that using GF mice for these experiments could address some of these
concerns. However, raising GF animals is still a highly specialized enterprise available
only at select institutions. Further studies of gene expression and metabolic output of
spore-forming bacteria may provide therapeutic targets for regulating T lymphocyte
responses to reduce autoimmune inﬂammation.
The mechanisms by which spore-forming bacteria regulate host T lymphocyte
differentiation remain to be discovered. Interestingly, an overlapping subset of bacterial
taxa has recently been shown to inhibit host proteases, including cathepsins (19), which
mediate adaptive immune responses by increasing Th17 (20) and limiting Treg differ-
entiation (21). Although future studies are needed to establish this ﬁrmly, it is possible
that spore-forming bacteria from controls, but not MS patients, are able to stimulate
Treg responses via cathepsin inhibition.
Furthermore, healthy human spore-forming bacteria both respond to fatty acid
presence in the environment and produce short-chain fatty acids (SCFAs), including
butyrate and acetate (22), which have been observed to stimulate Treg and inhibit Th1
differentiation in vitro and in vivo (23, 24). Either pure butyrate or butyrate-producing
spore-forming bacteria from healthy humans have been shown to be sufﬁcient for Treg
induction (25) in mice. Thus, human T lymphocyte differentiation into Tregs may be
driven by a yet-undiscovered SCFA-synthesizing subset of spore-forming bacteria that
is present in controls and absent in MS patients.
Akkermansia muciniphila has previously been reported to be increased in MS
patients compared to controls (10, 11, 26) and to have proinﬂammatory functions in
vitro (11). The proinﬂammatory functions of Akkermansia may stem from its ability to
induce thinning of intestinal mucosa. Indeed, MS patients present multiple gastroin-
testinal symptoms (27), which may be associated with differences in microbiome
community composition, including the increase in Akkermansia. Mucosal disturbances
have been previously reported to be sufﬁcient to induce both microbial dysbiosis and
immune impairments (28), which may account for an indirect proinﬂammatory effect of
increased Akkermansia.
In addition, Akkermansia has been shown to be resistant to broad-spectrum antibi-
otics (29), which in part may explain its persistence in mice colonized with spore-
forming bacteria. The fact that high levels of Akkermansia were seen only in mice
colonized with MS chloroform-resistant bacteria suggests that its population is nor-
mally regulated by commensals that are depleted in MS, thus enabling Akkermansia
overgrowth.
Our ﬁnding that Clostridium perfringens is more abundant in the spore-forming
bacterial fraction of MS patients is consistent with the association of C. perfringens with
neuromyelitis optica (NMO), another demyelinating autoimmune disease (30–32). Pu-
tative mechanisms of C. perfringens-mediated autoimmunity include molecular mimicry
between C. perfringens peptide and a self-antigen in the human host (30) and toxin-
mediated increase in neuronal damage (31, 33).
Due to the high variability of spore-forming bacteria across donors, mouse coloni-
zation with samples from additional donor pairs would be required to assess whether
MS-associated reduction in regulatory T lymphocyte differentiation in vitro can be
reliably reproduced in vivo. However, a major advantage of gnotobiotic as well as
antibiotic-treated and recolonized mouse models is the ability to assess the association
Cekanaviciute et al.
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between immune responses and microbial abundance within experimental communi-
ties. The identiﬁcation of additional taxa capable of inducing clear differentiation paths
in immune cells will further contribute to our understanding of their role in immune
regulation. For example, our ﬁndings corroborate the anti-inﬂammatory functions of
relatively unknown bacterial genera such as Anaeroplasma and Dehalobacterium in
mouse models of inﬂammation (34, 35).
In conclusion, we have investigated the immune functions of the spore-forming
fraction of human gut microbiota in health and disease, using MS as a model of
autoimmune inﬂammation. We identiﬁed novel bacterial taxa associated with MS as
well as with T lymphocyte differentiation into both proinﬂammatory and regulatory
phenotypes. Further studies of spore-forming bacteria and other experimentally de-
ﬁned bacterial populations may reveal speciﬁc immunoregulatory mechanisms in MS
and other diseases that may be targeted by therapeutic interventions.
MATERIALS AND METHODS
Isolation of spore-forming bacteria from human fecal samples. Fecal samples were collected
from 25 adult patients with RRMS who had not received disease-modifying or steroid treatment for at
least 3 months prior to the time of collection and 24 subjects without MS or any other autoimmune
disorder (controls) at the University of California, San Francisco (UCSF) (Table 1). The inclusion criteria
speciﬁed no use of antibiotics or oncologic therapeutics in 3 months prior to the study. All individuals
signed a written informed consent in accordance with the sampling procedure approved by the local
Institutional Review Board. Samples were stored in collection vials (Fisher no. NC9779954) at 80°C until
bacterial isolation.
Spore-forming bacteria were isolated based on their resistance to chloroform as described previously
(5). Brieﬂy, total bacteria were isolated from stool samples by suspending 0.5 mg stool sample in 1.5
ml PBS, passing it three times through a 70-m cell strainer and washing twice with 1.5 ml PBS by
spinning at 8,000 rpm. The resulting suspension was diluted in 5 ml PBS, mixed with chloroform to the
ﬁnal concentration of 3%, and incubated on a shaker for 1 h at room temperature. After incubation,
chloroform was removed from the solution by bubbling nitrogen (N2) gas for 30 min. Chloroform-treated
bacteria were then cultured on OxyPRAS brucella blood agar plates (Oxyrase no. P-BRU-BA) for 96 h
followed by brucella broth (Anaerobe Systems no. AS-105) for 48 h and isolated for sequencing, in vitro
experiments and in vivo experiments.
16S rRNA amplicon sequencing and computational analysis. DNA was extracted from mouse
fecal or human chloroform-resistant bacterial culture samples using the MoBio Power Fecal DNA
extraction kit (MoBio no. 12830) according to the manufacturer’s instructions. For each sample, PCR
targeting the V4 region of the prokaryotic 16S rRNA gene was completed in triplicate using the 515/806
primer pair, and amplicons were sequenced on NextSeq at the Microbiome Proﬁling Services core facility
at UCSF using the sequencing primers and procedures described in the Earth Microbiome Project
standard protocol (36). Analysis was performed using QIIME v1.9 as described (37). Essentially, amplicon
sequences were quality-ﬁltered and grouped to “species-level” OTUs via the SortMeRNA method (38),
using the Greengenes v.13.8 97% data set for closed reference. Sequences that did not match reference
sequences in the Greengenes database were dropped from analysis. Taxonomy was assigned to the
retained OTUs based on the Greengenes reference sequence, and the Greengenes tree was used for all
downstream phylogenetic community comparisons. OTUs were ﬁltered to retain only OTUs present in at
least 5% of samples and covering at least 100 total reads. After ﬁltering, samples were rareﬁed to 10,000
sequences per sample. Alpha diversity was calculated using the Chao1 method (39). For analysis of beta
diversity, pairwise distance matrices were generated using the phylogenetic metric unweighted UniFrac
(40) and used for principal coordinate analysis (PCoA). For comparison of individual taxa, samples were
not rareﬁed. Instead, OTU and taxa distributions were compared based on raw counts using the Wald
negative binomial test from R software package DESeq2 as described previously (41, 42) with Benjamini-
Hochberg correction for multiple comparisons. For visualization purposes, variance-stabilizing transfor-
mation was applied with local ﬁt type. Linear correlations between bacterial taxa and lymphocyte
proportions were computed after variance-stabilizing transformation of bacterial abundances (41).
TABLE 1 Subject characteristics
Feature Cases Controls
n 25 24
Proportion female (%) 80.0 12.5
Mean age, yr (SD) 44.0 (13.0) 49.3 (12.0)
Average BMI (SD) 23.8 (4.7) 24.2 (4.2)
Average disease duration, yr (SD) 13.5 (11.9) N/A
Proportion off-therapy (%) 28 N/A
Proportion therapy naive (%) 72 N/A
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Human sample sequencing was performed in two batches, and they were used as a covariate for
calculation.
Mouse colonization with microbiota. Female littermates, 5-week-old C57BL/6J mice (JAX no.
000664), cohoused at 5 mice per cage, were treated with a 1% solution of amphotericin B in drinking
water for 3 days, followed by 2 weeks of a solution composed of 1% amphotericin B, 1 mg/ml ampicillin,
1 mg/ml neomycin, 1 mg/ml metronidazole and 0.5 mg/ml vancomycin in drinking water. Cages were
changed weekly throughout the experiment using sterile technique. After 2 weeks, the drinking solution
was replaced by sterile water and mice were gavaged with speciﬁc bacteria of interest at 2 	 108 CFU
in 100 l per mouse every 2 days for 2 weeks (7 total gavages). Bacterial colonization was followed by
either the induction of EAE or immunophenotyping of mesenteric and cervical lymph nodes.
To induce EAE, mice were immunized in both ﬂanks with 0.1 ml MOG35-55 emulsion (1.5 mg/ml)
mixed with complete Freund’s adjuvant (CFA) and killed Mycobacterium tuberculosis H37Ra (2 mg/ml),
followed by two 0.1-ml intraperitoneal injections of pertussis toxin (2 g/ml) immediately and at 48 h
after MOG/CFA injections. Mice were scored daily in a blinded fashion for motor deﬁcits as follows: 0, no
deﬁcit; 1, limp tail only; 2, limp tail and hind limb weakness; 3, complete hind limb paralysis; 4, complete
hind limb paralysis and at least partial forelimb paralysis; 5, moribund. At the time of euthanasia, mouse
mesenteric lymph nodes and spleens were dissected and processed by grinding tissues through a 70-m
cell strainer. Entire mesenteric and cervical lymph nodes and 107 splenocytes per mouse were stimulated
for 4 to 5 h with 20 ng/ml PMA and 1 g/ml ionomycin in the presence of protein transport inhibitor
(GolgiPlug, BD no. 51-2301KZ) and used immediately for immunophenotyping, while the remaining
splenocytes were stored for in vitro bacterial stimulations. All animal research was approved by the
institutional animal care and use committee (IACUC) at UCSF.
Bacterial stimulation of human immune cells. Human peripheral blood mononuclear cells were
isolated from healthy volunteers and stored at 80°C in cryovials at a 107-cell/ml concentration in FBS
containing 10% DMSO. Before plating, cells were washed in PBS twice, recounted, and plated at a
106-cell/ml concentration in RPMI medium supplemented with 10% FBS and 1% penicillin-streptomycin-
glutamine. Cells were stimulated for 3 days as described previously (12) with anti-human CD3 (BD
no.555336, 0.3 g/ml), anti-human CD28 (BD no.555725, 2 g/ml) and recombinant human TGF-1 (R&D
no. 240B002, 2.5 ng/ml).
Bacteria isolated from human chloroform-resistant cultures were resuspended in PBS supplemented
with protease inhibitor (Roche no. 4693159001) and phosphatase inhibitor (Roche no. 4906845001),
heat-inactivated at 65°C for 1 h and sonicated for 10 min as described previously (14). Protein concen-
tration in the resulting suspension was measured using the Pierce BCA protein assay kit (Thermo
Scientiﬁc no. 23227). Bacterial extracts were added to PBMCs at 1 g/ml 1 h after plating as described
previously (13). PBS with the same protease inhibitor and phosphatase inhibitor was added as the
no-bacterium control. Each human in vitro experiment contained at least 6 independent donor bacterial
samples and was repeated at least twice.
Immunostaining, ﬂow cytometry and FACS of human immune cells. Human PBMCs were
immunostained using standard protocols. Live/dead cell gating was achieved using the Live/Dead
Fixable Aqua kit (ThermoFisher no. L34957). The FoxP3/transcription factor staining buffer set (eBiosci-
ence no. 00-5523-00) was used for staining of intracellular and intranuclear cytokines. The following
antibodies were used for human PBMC staining: anti-CD3-PE.Cy7 (BD no. 563423), anti-CD4-PerCP.Cy5.5
(BioLegend no. 300530), anti-CD25-APC (BD no. 555434), anti-FoxP3-Alexa Fluor 488 (BD no. 560047) and
anti-IL-10-PE (eBioscience no. 12-7108).
Flow cytometry was performed on a BD Fortessa cell analyzer and results were analyzed using FlowJo
software (TreeStar). Cells were gated to identify the lymphocyte population based on forward and side
scatter, followed by gating for single-color and live cell populations. Fluorescence minus one (FMO) was
used for gating. Unstained, single-color and ﬂuorescence-minus-one controls were used to identify
stained populations. For T lymphocyte suppression assay, control CD4 CD25 lymphocytes were sorted
from PBMC cultures incubated with extracts from unrelated control or MS spore-forming bacteria under
Treg-differentiating conditions on an Aria III cell sorter (BD Biosciences) and cultured with CD4 CD25
cells from the same donor preloaded with a CFSE cell division tracker kit. Statistical signiﬁcance of
expression changes in markers of T lymphocyte differentiation and proliferation was determined using
two-tailed Student’s t test to compare samples from different donors and two-tailed repeated measures
t test to compare samples from the same donor. GraphPad Prism 6 software was used to analyze and plot
the data. P 0.05 was considered statistically signiﬁcant.
Data availability. Raw and processed data are available at the UCSF datashare (DASH) platform
(https://doi.org/10.7272/Q6FB5136).
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